Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 953–960 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Biogen Inc. Felzartamab (MOR202) - (PROMINENT) Membranous nephropathy (MN) Phase 3 Enrollment Initiation Intravenous Immunology
Biogen Inc. SPINRAZA (Nusinersen) - (ASCEND) Spinal muscular atrophy (SMA) Phase 3 Trial Planned Intrathecal Genetic Disorder
Biogen Inc. Natalizumab - (NOVA) Multiple sclerosis (MS) Phase 3 Data Released Intravenous Neurology
Biogen Inc. BIIB131 (TMS-007) Acute ischemic stroke Phase 2 Trial Discontinued Intravenous Neurology
Biogen Inc. Felzartamab (MOR202) - (PROMINENT) Membranous nephropathy (MN) Phase 3 Enrollment Initiation Intravenous Immunology
Biogen Inc. SAGE-324 (BIIB124) - (KINETIC 2) Essential tremor Phase 2b Trial Discontinued Oral Neurology
Biogen Inc. Bardoxolone - (FALCON) Chronic Kidney Disease Phase 3 Trial Discontinued Oral N/A
Biogen Inc. Bardoxolone methyl - CATALYST Pulmonary arterial hypertension associated with connective tissue disease - CTD-PAH Phase 3 Trial Discontinued Oral Cardiology